The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
New Mayo Clinic approach to kidney transplants means more patients can be successfully transplanted

antibodies is discarded, and the red blood cells are reconstituted with saline solution, then put back in the patient's body. The next day, this is done again. And again the next day for several days. Each time, the antibody strength is diluted by half. Once the patient's antibody profile is so diluted it registers as a negative cross-match, the patient follows the regular course of all transplant patients of immunosuppressive drugs.

Significance of the Mayo Work

The Mayo Clinic study may change the heart-wrenching cycling through the donor-organ waiting list. Says Dr. Gloor, "The importance of this study is that we take a group of patients, and in a doable fashion with technology that is readily available today, we can now transplant these people who otherwise would never be transplanted."

Adds Dr. Stegall, "We've decided to take on these high-risk, difficult patients and just see if we can improve their outcomes -- and the answer is 'yes.' The results have been surprisingly good. However, we believe that this is only the beginning. These types of protocols are increasing our understanding of the role of antibody in kidney transplantation. We believe that the technology will continue to improve as we know more. There are thousands of patients out there who could benefit from this or similar therapy."


'"/>

Contact: Sara Lee
newsburea@mayo.edu
507-284-5005
Mayo Clinic
27-Aug-2003


Page: 1 2 3

Related medicine news :

1. Mayo Clinic discovers new pathway against pancreatic cancer
2. Mayo Clinic develops first genomic-based test to predict stroke from ruptured brain aneurysm
3. Mayo Clinic study sets threshold for valve repair surgery
4. Mayo Clinic researcher calls for improved newborn screening
5. Mayo Clinic study finds obese kidney donors face few increased risks
6. Mayo Clinic identifies key cellular process in prostate and other cancers
7. Clinical breast examination offers modest benefit to breast cancer screening program
8. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
9. Clinicians report missing patient information is common
10. Mayo Clinic discovers a key to low metabolism and major factor in obesity
11. Clinical trial of Etanercept for Wegeners disease shows no benefit

Post Your Comments:
(Date:11/25/2009)...ERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarti...rDrugEvaluationandResearch,titled"ADifficultBalanc...eNov.26,2009issueofTheNewEnglandJournalofMedicine....20090824/FDALOGO ) ,, Inthearticle,Woodcockdisc...medicationforthosewhoneeditandmanagingtheriskspose...
(Date:11/25/2009)...s have found evidence of a statistically significa...patients whose estrogen receptor (ER)-positive tum...; at serine-118 (ER-alpha S118-P), according to a ...n the Journal of the National Cancer Institute . ...istant to tamoxifen. Preclinical studies have show...
(Date:11/25/2009)... Evaluation and treatment clinics to ...Woodstock (Vocus) November 25, 2009 -- Centegra He...ines and H1N1 vaccine shots at four Centegra Prima...ipment of vaccine has arrived. The clinics are at ...McHenry and will be open as follows: ,   ...
(Date:11/25/2009)...NGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmeric...thCareFraudActof2009,"S.2128,whichisdesignedtosubs...tfraudinMedicare.ThebillwasintroducedbySen.GeorgeL...lprovisionstheAmericanAssociationforHomecareoutlin...ationproposedtoCongressinFebruary.Thoseprovisionsi...
(Date:11/25/2009)...ks placed under the skin kill tumor cells, study f...ews) -- A cancer vaccine delivered in a fingernail...a new study reports. , The method uses polymer ...d with tumor-specific antigens and implanted under... tumors. The Harvard University scientists who dev...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...WATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtradit...,anon-nucleosidereversetranscriptaseinhibitor(NNRT...useintreatment-experiencedadultswhoareexperiencing...andotherantiretroviral(ARV)agents.Thetraditionalap...nasDUET-1andDUET-2.INTELENCEiscurrentlymarketedint...
(Date:11/25/2009)...GRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,...romboticaptamerswithactivecontrolagents,announcedt...atthePiperJaffray21stAnnualHealthCareConferenceatt...tationwillbegivenat1:10pm(EST)onTuesday,December1a...mphasisontheleaddevelopmentprogram,theanticoagulan...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 1Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 2Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 3Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 4Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing 6189 5Webcast Alert 3A Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA 6184 1Webcast Alert 3A Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA 6184 2Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 1Understanding mechanical properties of silicon nanowires paves way for nanodevices 14797 2
Other News:
...searchers, funded by NWO, have determined the role... are located close to dying memory cells. The rese...disease. ...In patients with Alzheimers disease, ...es takes place primarily in the vicinity of so-cal...
ST. PAUL, MN Electrical brain stimulation can reduce the problems Parkinson's patients develop after long-term use of the drug levodopa, the main treatment for Parkinson's, according to a study publi
...L -- Treating depressed patients -- or those who l...nds -- with counseling and possibly psychotropic d...ower their risk of death or of having another atta...Carolina at Chapel Hill scientists and colleagues ...
CMS new reimbursement rate for FDG PET of $1375.00 has both good and disappointing news for those interested in bringing Positron Emission Tomography (PET) to the broadest number of patients, accordin
health news:The immune system and Alzheimers disease 2health news:Electrical brain stimulation reduces Parkinsons symptoms 2health news:New study: Treating depression, low social supports does not reduce heart patients deaths, heart attacks 2health news:New study: Treating depression, low social supports does not reduce heart patients deaths, heart attacks 3health news:SNM and ACNP CMS PET reimbursement statement 2
...NEW YORK, September 27, 2006 -- A gift from the es...ill enable Memorial Sloan-Kettering Cancer Center ... to be known as the Geoffrey Beene Cancer Research...scientific and clinical programs with the goal of ...
...The University of Rochester Medical Center will pa...e National Institutes of Health and the U.S. Food ...ds to assess the safety of drugs in clinical trial...ch, to be directed by Rochester researcher Jean-Ph...
Charlottesville, Va., September 26, 2006 -- The National Institutes of Health has awarded a $5.5 million grant over five years to the University of Virginia Health System to develop new, high tech ima
...Babies weighing less than the standard weight seem... irritable bowel syndrome or IBS, suggests researc...The Norwegian authors base their findings on 3334 ... completed a comprehensive questionnaire about the...
health news:Estate of fashion designer Geoffrey Beene donates funds to Memorial Sloan-Kettering Cancer Center 2health news:Rochester researchers join federal initiative to improve drug safety 2health news:Rochester researchers join federal initiative to improve drug safety 3health news:University of Virginia health system wins $5.5 million grant to help detect atherosclerosis 2health news:Restricted fetal growth increases risk of irritable bowel syndrome 2